article thumbnail

Marinus Pharmaceuticals Announces New Clinical and Research Data to be Presented at American Epilepsy Society Meeting

Cannabis Law Report

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

article thumbnail

Study on MDMA for Traumatic Brain Injury Boosted By $1.5M Donation

SpeedWeed

“Wesana is a serious, thoughtful and ethical company engaged in the development of psychedelic-assisted therapy. Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. Lately, MAPS research zeroed in on MDMA-assisted therapy for PTSD.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

MAPS: “California Psychedelic Decriminalization Bill Slated for 2023 Reintroduction”

Cannabis Law Report

SB 519 has served as a successful trial balloon for a state’s psychedelic drug policy, and we’ll take the lessons we’ve learned from this session as we look to gain more support for what was a popular and evidence-based piece of legislation. Policy and Advocacy Director, MAPS . Ismail Lourido Ali, J.D. ABOUT MAPS. September 1, 2022.

article thumbnail

Perez Hilton and Centuria Foods Launch New CBD Gummies, My True 10

Cannabis Law Report

–(BUSINESS WIRE)–Celebrity blogger and media personality Perez Hilton and leading hemp-based CBD researchers have forged a business partnership in support of My True 10 , a CBD Gummies line available at mytrue10.com Perez Hilton’s Personal Wellness Journey Encourages & Supports Others to Live Well. CARSON CITY, Nev.–(BUSINESS

Food 105
article thumbnail

Press Release: Maya and National Psychedelics Association Announce Partnership to Support Psilocybin-Assisted Services in Oregon

Cannabis Law Report

The Maya platform empowers psychedelic researchers, providers, and participants to collectively chart psychedelic best practices. The product suite includes a purpose-built Companion App for individuals, a Measurement Based Care Platform for providers, and a Real World Data Platform for both academic and commercial researchers.

article thumbnail

Breaking the Stigma: Shifting Attitudes Toward Medical Marijuana Nationwide

MMJ Recs

Historically, marijuana was vilified and classified as a Schedule I controlled substance, which hindered both research and public acceptance. Public discourse became more nuanced, with patients and advocacy groups championing the cause of medical marijuana as a legitimate and effective treatment option.

article thumbnail

Weekly Legislative Roundup 1/4/19

NORML

Steve Cohen (D-TN) and Don Young (R-AK) re-introduced the Compassionate Access, Research Expansion and Respect States (CARERS) Act, which protects those engaged in state-lawful medical marijuana programs from federal prosecution. The new Congress was just sworn in yesterday, and they are not wasting any time.